Condition: Castration-Resistant Prostatic Cancer · Metastasis · Sponsor: Merck Sharp & Dohme LLC
The purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with metastatic castration-resistant prostate cancer (mCRPC). The goals of this study are to learn about: * The safety of the study treatment and if people tolerate it. * A safe dose level of I-DXd that can be used with other treatments. * Participant levels of prostate specific antigen (PSA) during treatment.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| UCLA Hematology & Oncology ( Site 0003) | Los Angeles, California, United States | Recruiting |
| University of California-Irvine Medical Center ( Site 0016) | Orange, California, United States | Recruiting |
| UCSF Medical Center at Mission Bay ( Site 0034) | San Francisco, California, United States | Recruiting |
| MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) | Washington D.C., District of Columbia, United States | Recruiting |
| University of Michigan ( Site 0021) | Ann Arbor, Michigan, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center ( Site 0006) | New York, New York, United States | Recruiting |
| UPMC Hillman Cancer Center ( Site 0014) | Pittsburgh, Pennsylvania, United States | Recruiting |
| The West Clinic, PLLC dba West Cancer Center ( Site 0005) | Germantown, Tennessee, United States | Recruiting |
| Fred Hutchinson Cancer Center ( Site 0013) | Seattle, Washington, United States | Recruiting |
| Instituto Alexander Fleming ( Site 0202) | Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina | Recruiting |
| Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0200) | La Rioja, Argentina | Recruiting |
| Macquarie University-MQ Health Clinical Trials Unit ( Site 0801) | Macquarie University, New South Wales, Australia | Recruiting |
+ 70 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06863272